Physician profile
Raymond Grundmeyer
NPI 1346276961
$1,907,159.16
in general payments reported to CMS, 2019-2025
10 companies · $355K in 2025
The $355K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162K · 2020: $200K · 2021: $281K · 2022: $264K · 2023: $313K · 2024: $331K · 2025: $355K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $1,000K · Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $999,684.00 |
| Food and Beverage | $297.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midwest Surgical Alliance, LLC | $1,905,738.59 | 2019-2025 | |
| Providence Medical Technology, INC. | $423.70 | 2022-2023 | |
| Medtronic, INC. | $421.17 | 2021 | |
| Depuy Synthes Sales INC. | $185.21 | 2022-2023 | Synthecel |
| Kuros Biosciences USA, INC | $159.30 | 2022-2023 | |
| Cerapedics INC. | $87.61 | 2020 | |
| Medtronic USA, INC. | $79.73 | 2019 | |
| Orthofix Medical, INC. | $63.85 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,491,638.52 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Grundmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.